LEXISNEXIS® REED TECH TEAMS UP WITH REGDESK, A LEADING REGULATORY INFORMATION MANAGEMENT PLATFORM

The collaboration of the leading providers of Unique Device Identification (UDI) for global health authorities and RIMS compliance platform, supports global medical device companies.  HORSHAM, Pa., May 25, 2023 /PRNewswire/ — LexisNexis Legal & Professional today announced, that LexisNexis Reed Tech, provider of data management & analytic solutions for the life sciences industry, has expanded its … Read more

HARMONY BIOSCIENCES COMPLETES ENROLLMENT OF PHASE 3 REGISTRATIONAL INTUNE STUDY IN IDIOPATHIC HYPERSOMNIA

PLYMOUTH MEETING, Pa., May 25, 2023 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that its Phase 3 registrational INTUNE study evaluating the safety and efficacy of pitolisant in adult patients with idiopathic hypersomnia (IH) has … Read more

Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. … Read more

Remix Therapeutics to Present at Jefferies Healthcare Conference

CAMBRIDGE, Mass., May 25, 2023 /PRNewswire/ — Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 8, 2023, … Read more

KAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE CANCER MOONSHOT

Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum SYDNEY, May 25, 2023 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, has been invited to the White House to participate in the Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG), to … Read more

PetSmart Charities to Name Endowed Chair at UC Davis School of Veterinary Medicine with $6 Million Gift

National nonprofit makes this and other investments in higher education to bolster access to veterinary care PHOENIX, May 25, 2023 /PRNewswire/ — PetSmart Charities® will name an endowed chair at the University of California, Davis, School of Veterinary Medicine for $6 million. The landmark partnership marks the largest gift to date made by the top … Read more

National Safety Council Work to Zero Initiative Unveils New Research on Improving Workplace Safety with Robotics

White paper shows benefits of integrating technology to help reduce safety risks WASHINGTON, May 25, 2023 /PRNewswire/ — Despite concerted efforts to reduce both serious injury and death on the job, workplace fatality rates in the United States have remained largely unchanged over the past three decades. To help reverse this devastating development and assist organizations … Read more

Medtronic to acquire wearable insulin patch maker EOFlow

Acquisition will expand company’s ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support DUBLIN and SEONGNAM, South Korea, May 25, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. … Read more